Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    John Griffin

    TitleAdjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0912
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction
      NIH/NIAID U01AI133561Jun 5, 2017 - May 31, 2022
      Role: Co-Principal Investigator
      Human exomics genotyping-driven discovery and characterization of proteins related to clinical thrombosis, blood coagulation and thrombin generation
      NIH/NHLBI R01HL133728Sep 15, 2016 - Jul 31, 2020
      Role: Principal Investigator
      Murine Protein C and Protein S Proof of Principle Research
      NIH/NHLBI R01HL104074Jan 1, 2011 - Jul 31, 2011
      Role: Principal Investigator
      Griffin: Venous Thromboembolism and mass spectrometry-based untargeted metabolomi
      NIH/NHLBI RC1HL101034Sep 30, 2009 - Aug 31, 2012
      Role: Co-Principal Investigator
      Drug Engineering of Transglutaminase 2 Inhibitors
      NIH/NIDDK R41DK081244Feb 1, 2009 - Jan 31, 2011
      Role: Principal Investigator
      Novel targets and agents to treat thrombotic disorders
      NIH/NHLBI R01HL078684Sep 24, 2004 - Aug 31, 2005
      Role: Principal Investigator
      Structure and Function of Protein C
      NIH/NHLBI R01HL052246Dec 1, 1994 - Dec 31, 2017
      Role: Principal Investigator
      STRUCTURE AND FUNCTION OF PROTEIN C
      NIH/NHLBI R37HL052246Dec 1, 1994 - Dec 26, 2004
      Role: Principal Investigator
      IMPROVED FUNCTIONS FOR RECEPTOR LIKE ANTIBIOTICS
      NIH/NIGMS R01GM051122May 1, 1994 - Aug 31, 1998
      Role: Principal Investigator
      NOVEL SEMISYNTHETIC DERIVATIVES OF VANCOMYCIN
      NIH/NIGMS R21GM051122May 1, 1994 - Apr 30, 1996
      Role: Principal Investigator
      Thrombus Formation and Antithrombotic Intervention
      NIH/NHLBI P01HL031950Apr 1, 1984 - Jun 30, 2016
      Role: Principal Investigator
      PROTEIN C--AN ANTITHROMBOTIC-PROFIBRINOLYTIC AGENT
      NIH/NHLBI R01HL024891Aug 1, 1982 - Jul 31, 1992
      Role: Principal Investigator
      Proteins of Coagulation Pathways
      NIH/NHLBI R01HL021544Jul 1, 1977 - Aug 31, 2015
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Amar AP, Sagare AP, Zhao Z, Wang Y, Nelson AR, Griffin J, Zlokovic BV. Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology. 2017 Sep 18. PMID: 28923278.
        View in: PubMed
      2. Nazir S, Gadi I, Al-Dabet MM, Elwakiel A, Kohli S, Ghosh S, Manoharan J, Ranjan S, Bock F, Braun-Dullaeus RC, Esmon CT, Huber TB, Camerer E, Dockendorff C, Griffin J, Isermann B, Shahzad K. Cytoprotective activated protein C averts Nlrp3 inflammasome induced ischemia reperfusion injury via mTORC1 inhibition. Blood. 2017 Sep 07. PMID: 28882883.
        View in: PubMed
      3. Healy LD, Puy C, Fernández JA, Mitrugno A, Keshari RS, Taku NA, Chu TT, Xu X, Gruber A, Lupu F, Griffin J, McCarty OJT. Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J Biol Chem. 2017 May 26; 292(21):8616-8629. PMID: 28408624.
        View in: PubMed
      4. Griffin J, Mosnier LO, Fernández JA, Zlokovic BV. 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C. Arterioscler Thromb Vasc Biol. 2016 Nov; 36(11):2143-2151. PMID: 27758767.
        View in: PubMed
      5. Wang Y, Zhao Z, Rege SV, Wang M, Si G, Zhou Y, Wang S, Griffin J, Goldman SA, Zlokovic BV. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. Nat Med. 2016 Sep; 22(9):1050-5. PMID: 27548576.
        View in: PubMed
      6. Deguchi H, Sinha RK, Marchese P, Ruggeri ZM, Zilberman-Rudenko J, McCarty OJT, Cohen MJ, Griffin J. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va. Blood. 2016 Oct 06; 128(14):1870-1878. PMID: 27421960.
        View in: PubMed
      7. Burnier L, Boroujerdi A, Fernández JA, Welser-Alves JV, Griffin J, Milner R. Physiological cerebrovascular remodeling in response to chronic mild hypoxia: A role for activated protein C. Exp Neurol. 2016 Sep; 283(Pt A):396-403. PMID: 27412766; PMCID: PMC4992591 [Available on 09/01/17].
      8. Deguchi H, Banerjee Y, Elias DJ, Griffin J. Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism. J Atheroscler Thromb. 2016 Oct 01; 23(10):1159-1167. PMID: 27169917.
        View in: PubMed
      9. Griffin J, Fernández JA, Lyden PD, Zlokovic BV. Activated protein C promotes neuroprotection: mechanisms and translation to the clinic. Thromb Res. 2016 May; 141 Suppl 2:S62-4. PMID: 27207428; PMCID: PMC4904825 [Available on 05/01/17].
      10. Alsultan A, Gale AJ, Kurban K, Khalifah M, Albadr FB, Griffin J. Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis. Thromb Res. 2016 Jul; 143:17-21. PMID: 27172833; PMCID: PMC4943460 [Available on 07/01/17].
      11. Gale AJ, Bhat V, Pellequer JL, Griffin J, Mosnier LO, Von Drygalski A. Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding. Pharm Res. 2016 06; 33(6):1517-26. PMID: 26960296; PMCID: PMC4854778 [Available on 06/01/17].
      12. Sinha RK, Yang XV, Fernández JA, Xu X, Mosnier LO, Griffin J. Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization. Arterioscler Thromb Vasc Biol. 2016 Mar; 36(3):518-24. PMID: 26800564; PMCID: PMC4816599 [Available on 03/01/17].
      13. Bhat V, von Drygalski A, Gale AJ, Griffin J, Mosnier LO. Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa. Thromb Haemost. 2016 Mar; 115(3):551-61. PMID: 26466980; PMCID: PMC4775351 [Available on 02/28/17].
      14. Liang HP, Kerschen EJ, Basu S, Hernandez I, Zogg M, Jia S, Hessner MJ, Toso R, Rezaie AR, Fernández JA, Camire RM, Ruf W, Griffin J, Weiler H. Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. Blood. 2015 Nov 19; 126(21):2415-23. PMID: 26341257; PMCID: PMC4653768 [Available on 11/19/16].
      15. Amar AP, Griffin J, Zlokovic BV. Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke. Front Cell Neurosci. 2015; 9:344. PMID: 26388732; PMCID: PMC4556986.
      16. Yegneswaran S, Banerjee Y, Fernández JA, Deguchi H, Griffin J. Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex. PLoS One. 2015; 10(8):e0135025. PMID: 26263376; PMCID: PMC4532512.
      17. Banno F, Kita T, Fernández JA, Yanamoto H, Tashima Y, Kokame K, Griffin J, Miyata T. Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation. Blood. 2015 Nov 05; 126(19):2247-53. PMID: 26251307; PMCID: PMC4635119 [Available on 11/05/16].
      18. Deguchi H, Wolfbauer G, Cheung MC, Banerjee Y, Elias DJ, Fernández JA, Albers JJ, Griffin J. Inhibition of thrombin generation in human plasma by phospholipid transfer protein. Thromb J. 2015; 13:24. PMID: 26185485; PMCID: PMC4504036.
      19. Deguchi H, Banerjee Y, Trauger S, Siuzdak G, Kalisiak E, Fernández JA, Hoang L, Tran M, Yegneswaran S, Elias DJ, Griffin J. Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data. Blood. 2015 Sep 24; 126(13):1595-600. PMID: 26175037; PMCID: PMC4582336.
      20. Griffin J, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood. 2015 May 07; 125(19):2898-907. PMID: 25824691; PMCID: PMC4424414.
      21. Liang HP, Kerschen EJ, Hernandez I, Basu S, Zogg M, Botros F, Jia S, Hessner MJ, Griffin J, Ruf W, Weiler H. EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood. 2015 Apr 30; 125(18):2845-54. PMID: 25733582; PMCID: PMC4424632.
      22. Fernandez JA, Deguchi H, Banka CL, Witztum JL, Griffin J. Re-evaluation of the anticoagulant properties of high-density lipoprotein-brief report. Arterioscler Thromb Vasc Biol. 2015 Mar; 35(3):570-2. PMID: 25550205; PMCID: PMC4344393.
      23. Mosnier LO, Zlokovic BV, Griffin J. Cytoprotective-selective activated protein C therapy for ischaemic stroke. Thromb Haemost. 2014 Nov; 112(5):883-92. PMID: 25230930; PMCID: PMC4356129.
      24. von Drygalski A, Bhat V, Gale AJ, Burnier L, Cramer TJ, Griffin J, Mosnier LO. An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C. PLoS One. 2014; 9(8):e104304. PMID: 25127130; PMCID: PMC4134195.
      25. Winkler EA, Sengillo JD, Sagare AP, Zhao Z, Ma Q, Zuniga E, Wang Y, Zhong Z, Sullivan JS, Griffin J, Cleveland DW, Zlokovic BV. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci U S A. 2014 Mar 18; 111(11):E1035-42. PMID: 24591593; PMCID: PMC3964055.
      26. Deguchi H, Elias DJ, Trauger S, Zhang HM, Kalisiak E, Siuzdak G, Griffin J. Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids. Br J Haematol. 2014 May; 165(3):409-12. PMID: 24450944; PMCID: PMC3984601.
      27. Deguchi H, Elias DJ, Griffin J. Gain in translation: heme oxygenase-1 induced by activated protein C promotes thrombus resolution. J Thromb Haemost. 2014 Jan; 12(1):90-2. PMID: 24406066; PMCID: PMC4062081.
      28. von Drygalski A, Cramer TJ, Bhat V, Griffin J, Gale AJ, Mosnier LO. Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant. J Thromb Haemost. 2014; 12(3):363-72. PMID: 24818532; PMCID: PMC4161283.
      29. Mosnier LO, Fernández JA, Davis TP, Zlokovic BV, Griffin J. Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity. J Thromb Haemost. 2013 Nov; 11(11):2059-62. PMID: 24034518; PMCID: PMC3850769.
      30. Wang Y, Zhao Z, Chow N, Rajput PS, Griffin J, Lyden PD, Zlokovic BV. Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats. Stroke. 2013 Dec; 44(12):3529-36. PMID: 24159062; PMCID: PMC3912991.
      31. Heeb MJ, Mesters RM, Fernández JA, Hackeng TM, Nakasone RK, Griffin J. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation. Thromb Haemost. 2013 Aug; 110(2):275-82. PMID: 23892573; PMCID: PMC3733499.
      32. Guo H, Zhao Z, Yang Q, Wang M, Bell RD, Wang S, Chow N, Davis TP, Griffin J, Goldman SA, Zlokovic BV. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. J Neurosci. 2013 Apr 03; 33(14):6181-90. PMID: 23554499; PMCID: PMC3707621.
      33. Wang Y, Sinha RK, Mosnier LO, Griffin J, Zlokovic BV. Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice. Blood Cells Mol Dis. 2013 Aug; 51(2):104-8. PMID: 23541526; PMCID: PMC3812054.
      34. Wang Y, Zhao Z, Chow N, Ali T, Griffin J, Zlokovic BV. Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1. Brain Res. 2013 Apr 24; 1507:97-104. PMID: 23438513; PMCID: PMC3739836.
      35. von Drygalski A, Furlan-Freguia C, Ruf W, Griffin J, Mosnier LO. Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor. Arterioscler Thromb Vasc Biol. 2013 Apr; 33(4):769-76. PMID: 23393392; PMCID: PMC3735365.
      36. Burnier L, Fernández JA, Griffin J. Antibody SPC-54 provides acute in vivo blockage of the murine protein C system. Blood Cells Mol Dis. 2013 Apr; 50(4):252-8. PMID: 23385154; PMCID: PMC3594351.
      37. Lyden P, Levy H, Weymer S, Pryor K, Kramer W, Griffin J, Davis TP, Zlokovic B. Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr Pharm Des. 2013; 19(42):7479-85. PMID: 24372304; PMCID: PMC4040367.
      38. Deguchi H, Elias DJ, Navarro S, España F, Griffin J. Elevated serum amyloid A is associated with venous thromboembolism. Thromb Haemost. 2013 Feb; 109(2):358-9. PMID: 23255027; PMCID: PMC3579663.
      39. Van de Vijver P, Schmitt M, Suylen D, Scheer L, Thomassen MC, Schurgers LJ, Griffin J, Koenen RR, Hackeng TM. Incorporation of disulfide containing protein modules into multivalent antigenic conjugates: generation of antibodies against the thrombin-sensitive region of murine protein S. J Am Chem Soc. 2012 Nov 28; 134(47):19318-21. PMID: 23066897.
        View in: PubMed
      40. Mosnier LO, Sinha RK, Burnier L, Bouwens EA, Griffin J. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood. 2012 Dec 20; 120(26):5237-46. PMID: 23149848; PMCID: PMC3537315.
      41. von Drygalski A, Furlan-Freguia C, Mosnier LO, Yegneswaran S, Ruf W, Griffin J. Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux. Thromb Haemost. 2012 Nov; 108(5):981-91. PMID: 23052565; PMCID: PMC3597782.
      42. Wang Y, Zhang Z, Chow N, Davis TP, Griffin J, Chopp M, Zlokovic BV. An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke. 2012 Sep; 43(9):2444-9. PMID: 22811462; PMCID: PMC3429704.
      43. Geiger H, Pawar SA, Kerschen EJ, Nattamai KJ, Hernandez I, Liang HP, Fernández JÁ, Cancelas JA, Ryan MA, Kustikova O, Schambach A, Fu Q, Wang J, Fink LM, Petersen KU, Zhou D, Griffin J, Baum C, Weiler H, Hauer-Jensen M. Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity. Nat Med. 2012 Jul; 18(7):1123-9. PMID: 22729286; PMCID: PMC3491776.
      44. Griffin J, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012 Apr; 95(4):333-45. PMID: 22477541; PMCID: PMC3413316.
      45. Williams PD, Zlokovic BV, Griffin J, Pryor KE, Davis TP. Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. Curr Pharm Des. 2012; 18(27):4215-22. PMID: 22632606; PMCID: PMC3472038.
      46. Madhusudhan T, Wang H, Straub BK, Gröne E, Zhou Q, Shahzad K, Müller-Krebs S, Schwenger V, Gerlitz B, Grinnell BW, Griffin J, Reiser J, Gröne HJ, Esmon CT, Nawroth PP, Isermann B. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood. 2012 Jan 19; 119(3):874-83. PMID: 22117049; PMCID: PMC3398751.
      47. Raife TJ, Dwyre DM, Stevens JW, Erger RA, Leo L, Wilson KM, Fernández JA, Wilder J, Kim HS, Griffin J, Maeda N, Lentz SR. Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis. Arterioscler Thromb Vasc Biol. 2011 Nov; 31(11):2509-17. PMID: 21885846; PMCID: PMC3202707.
      48. Hansen JB, Fernández JA, Borch KH, Griffin J, Brox JH, Braekkan SK. Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism. Thromb Res. 2012 Apr; 129(4):502-7. PMID: 21777953; PMCID: PMC3480311.
      49. Bryk R, Wu K, Raimundo BC, Boardman PE, Chao P, Conn GL, Anderson E, Cole JL, Duffy NP, Nathan C, Griffin J. Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett. 2011 Jul 01; 21(13):4108-14. PMID: 21632247.
        View in: PubMed
      50. Zlokovic BV, Griffin J. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci. 2011 Apr; 34(4):198-209. PMID: 21353711; PMCID: PMC3491752.
      51. Guo H, Barrett TM, Zhong Z, Fernández JA, Griffin J, Freeman RS, Zlokovic BV. Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway. Mol Neurodegener. 2011 Feb 03; 6:13. PMID: 21291561; PMCID: PMC3042387.
      52. Bir N, Lafargue M, Howard M, Goolaerts A, Roux J, Carles M, Cohen MJ, Iles KE, Fernández JA, Griffin J, Pittet JF. Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice. Am J Respir Cell Mol Biol. 2011 Sep; 45(3):632-41. PMID: 21257925; PMCID: PMC3175583.
      53. Klöck C, Jin X, Choi K, Khosla C, Madrid PB, Spencer A, Raimundo BC, Boardman P, Lanza G, Griffin J. Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2. Bioorg Med Chem Lett. 2011 May 01; 21(9):2692-6. PMID: 21215619; PMCID: PMC3081996.
      54. Zhong Z, Wang Y, Guo H, Sagare A, Fernández JA, Bell RD, Barrett TM, Griffin J, Freeman RS, Zlokovic BV. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region. J Neurosci. 2010 Nov 17; 30(46):15521-34. PMID: 21084607; PMCID: PMC3012432.
      55. Kerschen E, Hernandez I, Zogg M, Jia S, Hessner MJ, Fernandez JA, Griffin J, Huettner CS, Castellino FJ, Weiler H. Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest. 2010 Sep; 120(9):3167-78. PMID: 20714108; PMCID: PMC2929901.
      56. Cramer TJ, Griffin J, Gale AJ. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va. Pathophysiol Haemost Thromb. 2010; 37(1):17-23. PMID: 20501981; PMCID: PMC2974842.
      57. Cheung MC, Albers JJ, Kennedy H, Deguchi H, Elias DJ, Averell PM, Griffin J, Marcovina SM. Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients. Clin Chim Acta. 2010 Sep 06; 411(17-18):1279-83. PMID: 20488173; PMCID: PMC3427714.
      58. Zhong Z, Ilieva H, Hallagan L, Bell R, Singh I, Paquette N, Thiyagarajan M, Deane R, Fernandez JA, Lane S, Zlokovic AB, Liu T, Griffin J, Chow N, Castellino FJ, Stojanovic K, Cleveland DW, Zlokovic BV. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J Clin Invest. 2009 Nov; 119(11):3437-49. PMID: 19841542.
        View in: PubMed
      59. Fernández JA, Heeb MJ, Xu X, Singh I, Zlokovic BV, Griffin J. Species-specific anticoagulant and mitogenic activities of murine protein S. Haematologica. 2009 Dec; 94(12):1721-31. PMID: 19815836; PMCID: PMC2791928.
      60. Saller F, Brisset AC, Tchaikovski SN, Azevedo M, Chrast R, Fernández JA, Schapira M, Hackeng TM, Griffin J, Angelillo-Scherrer A. Generation and phenotypic analysis of protein S-deficient mice. Blood. 2009 Sep 10; 114(11):2307-14. PMID: 19567881; PMCID: PMC2745849.
      61. Schuepbach RA, Feistritzer C, Fernández JA, Griffin J, Riewald M. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost. 2009 Apr; 101(4):724-33. PMID: 19350118; PMCID: PMC2680237.
      62. Guo H, Singh I, Wang Y, Deane R, Barrett T, Fernández JA, Chow N, Griffin J, Zlokovic BV. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity. Eur J Neurosci. 2009 Mar; 29(6):1119-30. PMID: 19302148; PMCID: PMC2692517.
      63. Mosnier LO, Zampolli A, Kerschen EJ, Schuepbach RA, Banerjee Y, Fernández JA, Yang XV, Riewald M, Weiler H, Ruggeri ZM, Griffin J. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood. 2009 Jun 04; 113(23):5970-8. PMID: 19244160; PMCID: PMC2700330.
      64. Heeb MJ, Prashun D, Griffin J, Bouma BN. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor. FASEB J. 2009 Jul; 23(7):2244-53. PMID: 19244162; PMCID: PMC2704590.
      65. Guo H, Wang Y, Singh I, Liu D, Fernández JA, Griffin J, Chow N, Zlokovic BV. Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity. J Neurochem. 2009 Apr; 109(1):116-24. PMID: 19166505; PMCID: PMC2692505.
      66. Niessen F, Furlan-Freguia C, Fernández JA, Mosnier LO, Castellino FJ, Weiler H, Rosen H, Griffin J, Ruf W. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood. 2009 Mar 19; 113(12):2859-66. PMID: 19141861; PMCID: PMC2661868.
      67. Yegneswaran S, Nguyen PM, Gale AJ, Griffin J. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C. Thromb Haemost. 2009 Jan; 101(1):55-61. PMID: 19132189; PMCID: PMC2730196.
      68. Cheung MC, Wolfbauer G, Deguchi H, Fernández JA, Griffin J, Albers JJ. Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. Biochim Biophys Acta. 2009 Mar; 1791(3):206-11. PMID: 19162221; PMCID: PMC2733856.
      69. Yang XV, Banerjee Y, Fernández JA, Deguchi H, Xu X, Mosnier LO, Urbanus RT, de Groot PG, White-Adams TC, McCarty OJ, Griffin J. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci U S A. 2009 Jan 06; 106(1):274-9. PMID: 19116273; PMCID: PMC2629184.
      70. Thiyagarajan M, Fernández JA, Lane SM, Griffin J, Zlokovic BV. Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1. J Neurosci. 2008 Nov 26; 28(48):12788-97. PMID: 19036971; PMCID: PMC2742231.
      71. Yegneswaran S, Hackeng TM, Dawson PE, Griffin J. The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa. J Biol Chem. 2008 Nov 28; 283(48):33046-52. PMID: 18784085; PMCID: PMC2586267.
      72. Pecheniuk NM, Elias DJ, Deguchi H, Averell PM, Griffin J. Elevated plasma fibronectin levels associated with venous thromboembolism. Thromb Haemost. 2008 Aug; 100(2):224-8. PMID: 18690341; PMCID: PMC2909754.
      73. Heeb MJ, Gandrille S, Fernandez JA, Griffin J, Fedullo PF. Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations. J Thromb Haemost. 2008 Jul; 6(7):1235-7. PMID: 18433462; PMCID: PMC2632602.
      74. White TC, Berny MA, Tucker EI, Urbanus RT, de Groot PG, Fernández JA, Griffin J, Gruber A, McCarty OJ. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost. 2008 Jun; 6(6):995-1002. PMID: 18489431.
        View in: PubMed
      75. Pecheniuk NM, Elias DJ, Xu X, Griffin J. Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry. Thromb Haemost. 2008 Feb; 99(2):453-5. PMID: 18278202.
        View in: PubMed
      76. Deguchi H, Fernández JA, Griffin J. Plasma cholesteryl ester transfer protein and blood coagulability. Thromb Haemost. 2007 Dec; 98(6):1160-4. PMID: 18064308.
        View in: PubMed
      77. Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, Mosnier LO, Castellino FJ, Mackman N, Griffin J, Weiler H. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007 Oct 01; 204(10):2439-48. PMID: 17893198; PMCID: PMC2118455.
      78. Mosnier LO, Yang XV, Griffin J. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions. J Biol Chem. 2007 Nov 09; 282(45):33022-33. PMID: 17872949.
        View in: PubMed
      79. Yegneswaran S, Kojima Y, Nguyen PM, Gale AJ, Heeb MJ, Griffin J. Factor Va residues 311-325 represent an activated protein C binding region. J Biol Chem. 2007 Sep 28; 282(39):28353-61. PMID: 17646160.
        View in: PubMed
      80. Griffin J, Fernández JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost. 2007 Jul; 5 Suppl 1:73-80. PMID: 17635713.
        View in: PubMed
      81. Gale AJ, Yegneswaran S, Xu X, Pellequer JL, Griffin J. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site. J Biol Chem. 2007 Jul 27; 282(30):21848-55. PMID: 17553804.
        View in: PubMed
      82. Eichinger S, Pecheniuk NM, Hron G, Deguchi H, Schemper M, Kyrle PA, Griffin J. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation. 2007 Mar 27; 115(12):1609-14. PMID: 17372172.
        View in: PubMed
      83. Gruber A, Marzec UM, Bush L, Di Cera E, Fernández JA, Berny MA, Tucker EI, McCarty OJ, Griffin J, Hanson SR. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates. Blood. 2007 May 01; 109(9):3733-40. PMID: 17227834; PMCID: PMC1874578.
      84. Raivio P, Fernández JA, Kuitunen A, Griffin J, Lassila R, Petäjä J. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007 Jan; 133(1):44-51. PMID: 17198779.
        View in: PubMed
      85. Mosnier LO, Zlokovic BV, Griffin J. The cytoprotective protein C pathway. Blood. 2007 Apr 15; 109(8):3161-72. PMID: 17110453.
        View in: PubMed
      86. Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, Liu D, Maggirwar SB, Deane R, Fernández JA, LaRue B, Griffin J, Chopp M, Zlokovic BV. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006 Nov; 12(11):1278-85. PMID: 17072311.
        View in: PubMed
      87. Radtke KP, Griffin J, Riceberg J, Gale AJ. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays. J Thromb Haemost. 2007 Jan; 5(1):102-8. PMID: 17059431.
        View in: PubMed
      88. Mosnier LO, Griffin J. Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. Front Biosci. 2006 Sep 01; 11:2381-99. PMID: 16720321.
        View in: PubMed
      89. Pecheniuk NM, Deguchi H, Elias DJ, Xu X, Griffin J. Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males. J Thromb Haemost. 2006 Sep; 4(9):2080-2. PMID: 16961620.
        View in: PubMed
      90. Fernández JA, Lentz SR, Dwyre DM, Griffin J. A novel ELISA for mouse activated protein C in plasma. J Immunol Methods. 2006 Jul 31; 314(1-2):174-81. PMID: 16828789.
        View in: PubMed
      91. Mineo C, Deguchi H, Griffin J, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006 Jun 09; 98(11):1352-64. PMID: 16763172.
        View in: PubMed
      92. Gale AJ, Radtke KP, Cunningham MA, Chamberlain D, Pellequer JL, Griffin J. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants. J Thromb Haemost. 2006 Jun; 4(6):1315-22. PMID: 16706977.
        View in: PubMed
      93. Feistritzer C, Schuepbach RA, Mosnier LO, Bush LA, Di Cera E, Griffin J, Riewald M. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J Biol Chem. 2006 Jul 21; 281(29):20077-84. PMID: 16709569.
        View in: PubMed
      94. Fernández JA, Pecheniuk NM, Deguchi H, Elias DJ, Griffin J. Is adiponectin implicated in venous thromboembolism? J Thromb Haemost. 2006 May; 4(5):1151-2. PMID: 16689775.
        View in: PubMed
      95. Fernández JA, Vento AE, Jormalainen M, Griffin J, Pesonen E, Syrjälä M, Repo H, Jansson SE, Rämö OJ, Petäjä J. Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects. Cardiovasc Drugs Ther. 2006 Apr; 20(2):113-21. PMID: 16761191.
        View in: PubMed
      96. Griffin J, Fernández JA, Mosnier LO, Liu D, Cheng T, Guo H, Zlokovic BV. The promise of protein C. Blood Cells Mol Dis. 2006 Mar-Apr; 36(2):211-6. PMID: 16464623.
        View in: PubMed
      97. Lindstrom O, Kylanpaa L, Mentula P, Puolakkainen P, Kemppainen E, Haapiainen R, Fernandez JA, Griffin J, Repo H, Petaja J. Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Crit Care. 2006 Feb; 10(1):R16. PMID: 16420659; PMCID: PMC1550818.
      98. Ilmakunnas M, Pesonen EJ, Höckerstedt K, Mäkisalo H, Fernandez JA, Griffin J, Repo H, Siitonen S, Petäjä J. Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation. Crit Care Med. 2006 Feb; 34(2):426-32. PMID: 16424724.
        View in: PubMed
      99. Gruber A, Fernández JA, Bush L, Marzec U, Griffin J, Hanson SR, DI Cera E. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates. J Thromb Haemost. 2006 Feb; 4(2):392-7. PMID: 16420571.
        View in: PubMed
      100. Tanaka KA, Fernández JA, Marzec UM, Kelly AB, Mohri M, Griffin J, Hanson SR, Gruber A. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates. Br J Haematol. 2006 Jan; 132(2):197-203. PMID: 16398653.
        View in: PubMed
      101. Turunen AJ, Fernández JA, Lindgren L, Salmela KT, Kyllönen LE, Mäkisalo H, Griffin J, Siitonen SM, Petäjä J, Pesonen EJ. Activated protein C reduces graft neutrophil activation in clinical renal transplantation. Am J Transplant. 2005 Sep; 5(9):2204-12. PMID: 16095499.
        View in: PubMed
      102. Zlokovic BV, Zhang C, Liu D, Fernandez J, Griffin J, Chopp M. Functional recovery after embolic stroke in rodents by activated protein C. Ann Neurol. 2005 Sep; 58(3):474-7. PMID: 16130108.
        View in: PubMed
      103. Deguchi H, Pecheniuk NM, Elias DJ, Averell PM, Griffin J. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation. 2005 Aug 09; 112(6):893-9. PMID: 16087810.
        View in: PubMed
      104. Deguchi H, Bouma BN, Middeldorp S, Lee YM, Griffin J. Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide. J Thromb Haemost. 2005 May; 3(5):935-8. PMID: 15869587.
        View in: PubMed
      105. Pecheniuk NM, Deguchi H, Griffin J. Cholesterol enhances phospholipid-dependent activated protein C anticoagulant activity. J Thromb Haemost. 2005 Feb; 3(2):340-5. PMID: 15670041.
        View in: PubMed
      106. Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, Young C, Thompson JA, Fernández JA, Griffin J, Eckhoff DE. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes. 2004 Nov; 53(11):2804-14. PMID: 15504960.
        View in: PubMed
      107. Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin J, Livneh A, Rosenberg N, Gelernter I, Gur H, Ehrenfeld M. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis. 2004 Nov; 63(11):1445-9. PMID: 15479893; PMCID: PMC1754810.
      108. Liu D, Cheng T, Guo H, Fernández JA, Griffin J, Song X, Zlokovic BV. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med. 2004 Dec; 10(12):1379-83. PMID: 15516929.
        View in: PubMed
      109. Yegneswaran S, Mesters RM, Fernández JA, Griffin J. Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex. J Biol Chem. 2004 Nov 19; 279(47):49019-25. PMID: 15331602.
        View in: PubMed
      110. Mosnier LO, Gale AJ, Yegneswaran S, Griffin J. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood. 2004 Sep 15; 104(6):1740-4. PMID: 15178575.
        View in: PubMed
      111. Griffin J, Fernández JA, Liu D, Cheng T, Guo H, Zlokovic BV. Activated protein C and ischemic stroke. Crit Care Med. 2004 May; 32(5 Suppl):S247-53. PMID: 15118526.
        View in: PubMed
      112. Guo H, Liu D, Gelbard H, Cheng T, Insalaco R, Fernández JA, Griffin J, Zlokovic BV. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004 Feb 19; 41(4):563-72. PMID: 14980205.
        View in: PubMed
      113. Gale AJ, Griffin J. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va. Proteins. 2004 Feb 15; 54(3):433-41. PMID: 14747992.
        View in: PubMed
      114. Deguchi H, Yegneswaran S, Griffin J. Sphingolipids as bioactive regulators of thrombin generation. J Biol Chem. 2004 Mar 26; 279(13):12036-42. PMID: 14722105.
        View in: PubMed
      115. McDougal PG, Griffin J. Enantiotracin. Bioorg Med Chem Lett. 2003 Jul 07; 13(13):2239-40. PMID: 12798342.
        View in: PubMed
      116. Mosnier LO, Griffin J. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor. Biochem J. 2003 Jul 01; 373(Pt 1):65-70. PMID: 12683950; PMCID: PMC1223481.
      117. Griffin J, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7830-5. PMID: 12808148; PMCID: PMC164673.
      118. Yegneswaran S, Mesters RM, Griffin J. Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex. J Biol Chem. 2003 Aug 29; 278(35):33312-8. PMID: 12805370.
        View in: PubMed
      119. Griffin J, Linsell MS, Nodwell MB, Chen Q, Pace JL, Quast KL, Krause KM, Farrington L, Wu TX, Higgins DL, Jenkins TE, Christensen BG, Judice JK. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. J Am Chem Soc. 2003 May 28; 125(21):6517-31. PMID: 12785792.
        View in: PubMed
      120. Fernández JA, Xu X, Liu D, Zlokovic BV, Griffin J. Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol Dis. 2003 May-Jun; 30(3):271-6. PMID: 12737945.
        View in: PubMed
      121. Liu D, Guo H, Griffin J, Fernández JA, Zlokovic BV. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. Circulation. 2003 Apr 08; 107(13):1791-6. PMID: 12665496.
        View in: PubMed
      122. Slungaard A, Fernandez JA, Griffin J, Key NS, Long JR, Piegors DJ, Lentz SR. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood. 2003 Jul 01; 102(1):146-51. PMID: 12609838.
        View in: PubMed
      123. Ilmakunnas M, Petäjä J, Höckerstedt K, Mäkisalo H, Fernandez JA, Griffin J, Jansson SE, Repo H, Pesonen EJ. Activation of protein C during reperfusion in clinical liver transplantation. Transplantation. 2003 Feb 27; 75(4):467-72. PMID: 12605111.
        View in: PubMed
      124. Dömötör E, Benzakour O, Griffin J, Yule D, Fukudome K, Zlokovic BV. Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood. 2003 Jun 15; 101(12):4797-801. PMID: 12586611.
        View in: PubMed
      125. Cheng T, Liu D, Griffin J, Fernández JA, Castellino F, Rosen ED, Fukudome K, Zlokovic BV. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003 Mar; 9(3):338-42. PMID: 12563316.
        View in: PubMed
      126. Yegneswaran S, Deguchi H, Griffin J. Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human- and bovine-activated protein C with negatively charged phospholipid vesicles. J Biol Chem. 2003 Apr 25; 278(17):14614-21. PMID: 12560338.
        View in: PubMed
      127. Khrenov AV, Ananyeva NM, Griffin J, Saenko EL. Coagulation pathways in atherothrombosis. Trends Cardiovasc Med. 2002 Oct; 12(7):317-24. PMID: 12458095.
        View in: PubMed
      128. Lentz SR, Piegors DJ, Fernández JA, Erger RA, Arning E, Malinow MR, Griffin J, Bottiglieri T, Haynes WG, Heistad DD. Effect of hyperhomocysteinemia on protein C activation and activity. Blood. 2002 Sep 15; 100(6):2108-12. PMID: 12200374.
        View in: PubMed
      129. Heeb MJ, Paganini-Hill A, Griffin J, Fisher M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis. 2002 Sep-Oct; 29(2):139-44. PMID: 12490280.
        View in: PubMed
      130. Gale AJ, Xu X, Pellequer JL, Getzoff ED, Griffin J. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C. Protein Sci. 2002 Sep; 11(9):2091-101. PMID: 12192065; PMCID: PMC2373598.
      131. Heeb MJ, Griffin J. Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements. Blood Cells Mol Dis. 2002 Sep-Oct; 29(2):190-9. PMID: 12490286.
        View in: PubMed
      132. Lentz SR, Miller FJ, Piegors DJ, Erger RA, Fernández JA, Griffin J, Heistad DD. Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys. Circulation. 2002 Aug 13; 106(7):842-6. PMID: 12176958.
        View in: PubMed
      133. Simmelink MJ, de Groot PG, Derksen RH, Fernandez JA, Griffin J. Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors. Blood. 2002 Dec 01; 100(12):4232-3. PMID: 12393585.
        View in: PubMed
      134. Kottke-Marchant K, Bahit MC, Granger CB, Zoldhelyi P, Ardissino D, Brooks L, Griffin J, Potthoff RF, Van de Werf F, Califf RM, Topol EJ. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy. Eur Heart J. 2002 Aug; 23(15):1202-12. PMID: 12127922.
        View in: PubMed
      135. Wu TK, Griffin J. Conversion of a plant oxidosqualene-cycloartenol synthase to an oxidosqualene-lanosterol cyclase by random mutagenesis. Biochemistry. 2002 Jul 02; 41(26):8238-44. PMID: 12081472.
        View in: PubMed
      136. Griffin J, Zlokovic B, Fernández JA. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol. 2002 Jul; 39(3):197-205. PMID: 12124682.
        View in: PubMed
      137. Fernández JA, Gruber A, Heeb MJ, Griffin J. Protein C pathway impairment in nonsymptomatic cigarette smokers. Blood Cells Mol Dis. 2002 Jul-Aug; 29(1):73-82. PMID: 12482406.
        View in: PubMed
      138. Gale AJ, Tsavaler A, Griffin J. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C. J Biol Chem. 2002 Aug 09; 277(32):28836-40. PMID: 12063259.
        View in: PubMed
      139. Simmelink MJ, Fernández JA, Derksen RH, Griffin J, de Groot PG. Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II. Br J Haematol. 2002 Jun; 117(3):676-84. PMID: 12028041.
        View in: PubMed
      140. Yegneswaran S, Fernández JA, Griffin J, Dawson PE. Factor Va increases the affinity of factor Xa for prothrombin: a binding study using a novel photoactivable thiol-specific fluorescent probe. Chem Biol. 2002 Apr; 9(4):485-94. PMID: 11983337.
        View in: PubMed
      141. Deguchi H, Fernández JA, Griffin J. Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S. J Biol Chem. 2002 Mar 15; 277(11):8861-5. PMID: 11741960.
        View in: PubMed
      142. Griffin J, Fernández JA, Deguchi H. Plasma lipoproteins, hemostasis and thrombosis. Thromb Haemost. 2001 Jul; 86(1):386-94. PMID: 11487028.
        View in: PubMed
      143. Petäjä J, Pesonen E, Fernández JA, Griffin J, Repo H, Jansson SE, Vento AE, Rämö OJ. Activated protein C and inflammation in human myocardium after heart surgery. Am J Hematol. 2001 Jul; 67(3):210-2. PMID: 11391722.
        View in: PubMed
      144. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin J, Zlokovic BV. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001 Apr 03; 103(13):1799-805. PMID: 11282913.
        View in: PubMed
      145. Buckner FS, Griffin J, Wilson AJ, Van Voorhis WC. Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Antimicrob Agents Chemother. 2001 Apr; 45(4):1210-5. PMID: 11257036; PMCID: PMC90445.
      146. Deguchi H, Fernández JA, Pabinger I, Heit JA, Griffin J. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway. Blood. 2001 Apr 01; 97(7):1907-14. PMID: 11264150.
        View in: PubMed
      147. Grody WW, Griffin J, Taylor AK, Korf BR, Heit JA. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med. 2001 Mar-Apr; 3(2):139-48. PMID: 11280951; PMCID: PMC3111091.
      148. Rintelen C, Yegneswaran S, Griffin J. Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation. Thromb Haemost. 2001 Feb; 85(2):274-9. PMID: 11246547.
        View in: PubMed
      149. Hackeng TM, Fernández JA, Dawson PE, Kent SB, Griffin J. Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S. Proc Natl Acad Sci U S A. 2000 Dec 19; 97(26):14074-8. PMID: 11106381; PMCID: PMC18873.
      150. Pellequer JL, Gale AJ, Getzoff ED, Griffin J. Three-dimensional model of coagulation factor Va bound to activated protein C. Thromb Haemost. 2000 Nov; 84(5):849-57. PMID: 11127867.
        View in: PubMed
      151. Hackeng TM, Yegneswaran S, Johnson AE, Griffin J. Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S. Biochem J. 2000 Aug 01; 349 Pt 3:757-64. PMID: 10903136; PMCID: PMC1221202.
      152. Gale AJ, Heeb MJ, Griffin J. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites. Blood. 2000 Jul 15; 96(2):585-93. PMID: 10887122.
        View in: PubMed
      153. Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin J, Hartman DL. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med. 2000 Jul; 28(7):2209-16. PMID: 10921542.
        View in: PubMed
      154. Marx PF, Hackeng TM, Dawson PE, Griffin J, Meijers JC, Bouma BN. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. J Biol Chem. 2000 Apr 28; 275(17):12410-5. PMID: 10777524.
        View in: PubMed
      155. Fernández JA, Kojima K, Petäjä J, Hackeng TM, Griffin J. Cardiolipin enhances protein C pathway anticoagulant activity. Blood Cells Mol Dis. 2000 Apr; 26(2):115-23. PMID: 10753602.
        View in: PubMed
      156. Deguchi H, Fernandez JA, Hackeng TM, Banka CL, Griffin J. Cardiolipin is a normal component of human plasma lipoproteins. Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1743-8. PMID: 10677528; PMCID: PMC26506.
      157. Gale AJ, Pellequer JL, Getzoff ED, Griffin J. Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII. Thromb Haemost. 2000 Jan; 83(1):78-85. PMID: 10669159.
        View in: PubMed
      158. Griffin J, Deguchi H, Fernandez JA. Causes of thrombophilia yet to be discovered: a personal view. Haemostasis. 2000; 30 Suppl 2:26-33. PMID: 11251338.
        View in: PubMed
      159. Heeb MJ, Kojima Y, Rosing J, Tans G, Griffin J. C-terminal residues 621-635 of protein S are essential for binding to factor Va. J Biol Chem. 1999 Dec 17; 274(51):36187-92. PMID: 10593904.
        View in: PubMed
      160. Bouma BN, Mosnier LO, Meijers JC, Griffin J. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation. Thromb Haemost. 1999 Dec; 82(6):1703-8. PMID: 10613658.
        View in: PubMed
      161. Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, Griffin J, Carmeliet P, Weiss MH, Zlokovic BV. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol. 1999 Nov; 19(11):2801-6. PMID: 10559029.
        View in: PubMed
      162. Fernández JA, Petäjä J, Griffin J. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Thromb Haemost. 1999 Nov; 82(5):1462-8. PMID: 10595639.
        View in: PubMed
      163. Petäjä J, Pesonen E, Fernández JA, Vento AE, Rämö OJ, Griffin J. Cardiopulmonary bypass and activation of antithrombotic plasma protein C. J Thorac Cardiovasc Surg. 1999 Sep; 118(3):422-9; discussion 429-31. PMID: 10469954.
        View in: PubMed
      164. Hackeng TM, Griffin J, Dawson PE. Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology. Proc Natl Acad Sci U S A. 1999 Aug 31; 96(18):10068-73. PMID: 10468563; PMCID: PMC17843.
      165. Zivelin A, Gitel S, Griffin J, Xu X, Fernandez JA, Martinowitz U, Cohen Y, Halkin H, Seligsohn U, Inbal A. Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood. 1999 Aug 01; 94(3):895-901. PMID: 10419879.
        View in: PubMed
      166. Lentz SR, Fernández JA, Griffin J, Piegors DJ, Erger RA, Malinow MR, Heistad DD. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system. Arterioscler Thromb Vasc Biol. 1999 Jul; 19(7):1744-50. PMID: 10397693.
        View in: PubMed
      167. Xu X, Bauer KA, Griffin J. Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms. Thromb Res. 1999 Mar 15; 93(6):265-9. PMID: 10093967.
        View in: PubMed
      168. Macko RF, Killewich LA, Fernández JA, Cox DK, Gruber A, Griffin J. Brain-specific protein C activation during carotid artery occlusion in humans. Stroke. 1999 Mar; 30(3):542-5. PMID: 10066849.
        View in: PubMed
      169. Griffin J, Kojima K, Banka CL, Curtiss LK, Fernández JA. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest. 1999 Jan; 103(2):219-27. PMID: 9916134; PMCID: PMC407881.
      170. Pellequer JL, Gale AJ, Griffin J, Getzoff ED. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol Dis. 1998 Dec; 24(4):448-61. PMID: 9880241.
        View in: PubMed
      171. Petäjä J, Fernández JA, Fellman V, Griffin J. Upregulation of the antithrombotic protein C pathway at birth. Pediatr Hematol Oncol. 1998 Nov-Dec; 15(6):489-99. PMID: 9842642.
        View in: PubMed
      172. Mounier CM, Hackeng TM, Schaeffer F, Faure G, Bon C, Griffin J. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa. J Biol Chem. 1998 Sep 11; 273(37):23764-72. PMID: 9726985.
        View in: PubMed
      173. Hackeng TM, Dawson PE, Kent SB, Griffin J. Chemical synthesis of human protein S thrombin-sensitive module and first epidermal growth factor module. Biopolymers. 1998 Aug; 46(2):53-63. PMID: 9664841.
        View in: PubMed
      174. Kojima Y, Heeb MJ, Gale AJ, Hackeng TM, Griffin J. Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va. J Biol Chem. 1998 Jun 12; 273(24):14900-5. PMID: 9614093.
        View in: PubMed
      175. Fernández JA, Griffin J, Chang GT, Stam J, Reitsma PH, Bertina RM, Bouma BN. Involvement of amino acid residues 423-429 of human protein S in binding to C4b-binding protein. Blood Cells Mol Dis. 1998 Jun; 24(2):101-12; discussion 113. PMID: 9628846.
        View in: PubMed
      176. Petäjä J, Hakala L, Rasi V, Griffin J. Circulating activated protein C in subjects with heterozygous Gln506-factor V. Haemostasis. 1998 Jan-Feb; 28(1):31-6. PMID: 9885368.
        View in: PubMed
      177. Petäjä JM, Griffin J. Activated protein C resistance: What have we learned now that the dust has settled? Ann Med. 1997 Dec; 29(6):469-72. PMID: 9562511.
        View in: PubMed
      178. Wang L, Zoppè M, Hackeng TM, Griffin J, Lee KF, Verma IM. A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci U S A. 1997 Oct 14; 94(21):11563-6. PMID: 9326649; PMCID: PMC23538.
      179. Smiley ST, Boyer SN, Heeb MJ, Griffin J, Grusby MJ. Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc Natl Acad Sci U S A. 1997 Oct 14; 94(21):11484-9. PMID: 9326636; PMCID: PMC23513.
      180. Fernández JA, Petäjä J, Gruber A, Griffin J. Activated protein C correlates inversely with thrombin levels in resting healthy individuals. Am J Hematol. 1997 Sep; 56(1):29-31. PMID: 9298864.
        View in: PubMed
      181. Hackeng TM, Mounier CM, Bon C, Dawson PE, Griffin J, Kent SB. Total chemical synthesis of enzymatically active human type II secretory phospholipase A2. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):7845-50. PMID: 9223275; PMCID: PMC21517.
      182. Fernández JA, Hackeng TM, Kojima K, Griffin J. The carbohydrate moiety of factor V modulates inactivation by activated protein C. Blood. 1997 Jun 15; 89(12):4348-54. PMID: 9192757.
        View in: PubMed
      183. Petäjä J, Fernández JA, Gruber A, Griffin J. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C. J Clin Invest. 1997 Jun 01; 99(11):2655-63. PMID: 9169495; PMCID: PMC508111.
      184. Fernández JA, Heeb MJ, Radtke KP, Griffin J. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor. Biol Reprod. 1997 Mar; 56(3):757-63. PMID: 9047022.
        View in: PubMed
      185. Zivelin A, Griffin J, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood. 1997 Jan 15; 89(2):397-402. PMID: 9002940.
        View in: PubMed
      186. Gale AJ, Sun X, Heeb MJ, Griffin J. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Protein Sci. 1997 Jan; 6(1):132-40. PMID: 9007985; PMCID: PMC2143509.
      187. Macko RF, Ameriso SF, Gruber A, Griffin J, Fernandez JA, Barndt R, Quismorio FP, Weiner JM, Fisher M. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke. 1996 Nov; 27(11):2005-11. PMID: 8898806.
        View in: PubMed
      188. Petäjä J, Lundström U, Sairanen H, Marttinen E, Griffin J. Central venous thrombosis after cardiac operations in children. J Thorac Cardiovasc Surg. 1996 Oct; 112(4):883-9. PMID: 8873713.
        View in: PubMed
      189. Heeb MJ, Kojima Y, Hackeng TM, Griffin J. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Protein Sci. 1996 Sep; 5(9):1883-9. PMID: 8880912; PMCID: PMC2143529.
      190. Gravert DJ, Griffin J. Steric and Electronic Effects, Enantiospecificity, and Reactive Orientation in DNA Binding/Cleaving by Substituted Derivatives of [SalenMn(III)](+). Inorg Chem. 1996 Aug 14; 35(17):4837-4847. PMID: 11666683.
        View in: PubMed
      191. Brenner B, Zivelin A, Lanir N, Greengard JS, Griffin J, Seligsohn U. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Blood. 1996 Aug 01; 88(3):877-80. PMID: 8704244.
        View in: PubMed
      192. Fisher M, Fernandez JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin J. Activated protein C resistance in ischemic stroke not due to factor V arginine506-->glutamine mutation. Stroke. 1996 Jul; 27(7):1163-6. PMID: 8685921.
        View in: PubMed
      193. Lee J, Griffin J, Nicas TI. Solid-Phase Total Synthesis of Bacitracin A. J Org Chem. 1996 Jun 14; 61(12):3983-3986. PMID: 11667271.
        View in: PubMed
      194. España F, Sánchez-Cuenca J, Estellés A, Gilabert J, Griffin J, Heeb MJ. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin. Clin Chem. 1996 Apr; 42(4):545-50. PMID: 8605671.
        View in: PubMed
      195. Goldman RC, Zakula D, Capobianco JO, Sharpe BA, Griffin J. Inhibition of 2,3-oxidosqualene-lanosterol cyclase in Candida albicans by pyridinium ion-based inhibitors. Antimicrob Agents Chemother. 1996 Apr; 40(4):1044-7. PMID: 8849227; PMCID: PMC163259.
      196. Sifontes MT, Nuss R, Jacobson LJ, Griffin J, Manco-Johnson MJ. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr. 1996 Mar; 128(3):324-8. PMID: 8774498.
        View in: PubMed
      197. Gillespie DL, Carrington LR, Griffin J, Alving BM. Resistance to activated protein C: a common inherited cause of venous thrombosis. Ann Vasc Surg. 1996 Mar; 10(2):174-7. PMID: 8733870.
        View in: PubMed
      198. Rose IC, Sharpe BA, Lee RC, Griffin J, Capobianco JO, Zakula D, Goldman RC. Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents. Bioorg Med Chem. 1996 Jan; 4(1):97-103. PMID: 8689245.
        View in: PubMed
      199. Radtke KP, Greengard JS, Fernández JA, Villoutreix BO, Griffin J. A two-allele polymorphism in protein C inhibitor with varying frequencies in different ethnic populations. Thromb Haemost. 1996 Jan; 75(1):62-9. PMID: 8713781.
        View in: PubMed
      200. Gravert DJ, Griffin J. Specific DNA cleavage by manganese(III) complexes. Met Ions Biol Syst. 1996; 33:515-36. PMID: 8742854.
        View in: PubMed
      201. Villoutreix BO, Fernández JA, Teleman O, Griffin J. Comparative modeling of the three CP modules of the beta-chain of C4BP and evaluation of potential sites of interaction with protein S. Protein Eng. 1995 Dec; 8(12):1253-8. PMID: 8869637.
        View in: PubMed
      202. Greengard JS, Xu X, Gandrille S, Griffin J. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V. Thromb Res. 1995 Dec 01; 80(5):441-3. PMID: 8588206.
        View in: PubMed
      203. Griffin J. Blood coagulation. The thrombin paradox. Nature. 1995 Nov 23; 378(6555):337-8. PMID: 7477366.
        View in: PubMed
      204. Heeb MJ, España F, Gittes RF, Griffin J. Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera. Biochem Mol Biol Int. 1995 Nov; 37(5):917-23. PMID: 8624498.
        View in: PubMed
      205. Spek CA, Greengard JS, Griffin J, Bertina RM, Reitsma PH. Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem. 1995 Oct 13; 270(41):24216-21. PMID: 7592627.
        View in: PubMed
      206. Radtke KP, Fernández JA, Villoutreix BO, Greengard JS, Griffin J. Characterization of a cDNA for rhesus monkey protein C inhibitor--evidence for N-terminal involvement in heparin stimulation. Thromb Haemost. 1995 Oct; 74(4):1079-87. PMID: 8560417.
        View in: PubMed
      207. Griffin J. A conference of crosstalk: the Gordon Research Conference in Bioorganic Chemistry. Chem Biol. 1995 Aug; 2(8):501-2. PMID: 9383452.
        View in: PubMed
      208. Griffin J, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS. Activated protein C resistance: molecular mechanisms. Thromb Haemost. 1995 Jul; 74(1):444-8. PMID: 8578503.
        View in: PubMed
      209. Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin J, Aiach M. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. Blood. 1995 Jul 01; 86(1):219-24. PMID: 7795227.
        View in: PubMed
      210. Heeb MJ, Kojima Y, Greengard JS, Griffin J. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood. 1995 Jun 15; 85(12):3405-11. PMID: 7780127.
        View in: PubMed
      211. Le DT, Griffin J, Greengard JS, Mujumdar V, Rapaport SI. Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. Blood. 1995 Apr 01; 85(7):1704-11. PMID: 7703480.
        View in: PubMed
      212. Greengard JS, Fernandez JA, Radtke KP, Griffin J. Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C. Biochem J. 1995 Jan 15; 305 ( Pt 2):397-403. PMID: 7832752; PMCID: PMC1136375.
      213. Calkins T, Greengard J, Griffin J, Bylund D. Anticoagulant response to activated protein C: method validation and assay comparison. J Clin Lab Anal. 1995; 9(6):418-23. PMID: 8587012.
        View in: PubMed
      214. Greengard JS, Eichinger S, Griffin J, Bauer KA. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V. N Engl J Med. 1994 Dec 08; 331(23):1559-62. PMID: 7969326.
        View in: PubMed
      215. Greengard JS, Griffin J, Fisher CL. Possible structural implications of 20 mutations in the protein C protease domain. Thromb Haemost. 1994 Dec; 72(6):869-73. PMID: 7740456.
        View in: PubMed
      216. Villoutreix BO, Getzoff ED, Griffin J. A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci. 1994 Nov; 3(11):2033-44. PMID: 7535613; PMCID: PMC2142655.
      217. Radtke KP, Fernández JA, Greengard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin J. Protein C inhibitor is expressed in tubular cells of human kidney. J Clin Invest. 1994 Nov; 94(5):2117-24. PMID: 7525654; PMCID: PMC294656.
      218. Fernández JA, Villoutreix BO, Hackeng TM, Griffin J, Bouma BN. Analysis of protein S C4b-binding protein interactions by homology modeling and inhibitory antibodies. Biochemistry. 1994 Sep 20; 33(37):11073-8. PMID: 7727359.
        View in: PubMed
      219. Tsay W, Greengard JS, Griffin J. Exonic polymorphisms in the protein C gene: interethnic comparison between Caucasians and Asians. Hum Genet. 1994 Aug; 94(2):177-8. PMID: 8045564.
        View in: PubMed
      220. Shi Z, Buntel CJ, Griffin J. Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1994 Jul 19; 91(15):7370-4. PMID: 8041797; PMCID: PMC44401.
      221. Sun X, Evatt B, Griffin J. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood. 1994 Jun 01; 83(11):3120-5. PMID: 8193349.
        View in: PubMed
      222. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin J, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 1994 May 28; 343(8909):1361-2. PMID: 7910348.
        View in: PubMed
      223. Gruber A, Mori E, del Zoppo GJ, Waxman L, Griffin J. Alteration of fibrin network by activated protein C. Blood. 1994 May 01; 83(9):2541-8. PMID: 8167339.
        View in: PubMed
      224. Fisher CL, Greengard JS, Griffin J. Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen. Protein Sci. 1994 Apr; 3(4):588-99. PMID: 8003977; PMCID: PMC2142866.
      225. Greengard JS, Fisher CL, Villoutreix B, Griffin J. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins. 1994 Apr; 18(4):367-80. PMID: 8208728.
        View in: PubMed
      226. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin J. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2728-32. PMID: 8146182; PMCID: PMC43443.
      227. Fernández JA, Griffin J. A protein S binding site on C4b-binding protein involves beta chain residues 31-45. J Biol Chem. 1994 Jan 28; 269(4):2535-40. PMID: 8300581.
        View in: PubMed
      228. España F, Estellés A, Fernández PJ, Gilabert J, Sánchez-Cuenca J, Griffin J. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma. Thromb Haemost. 1993 Dec 20; 70(6):989-94. PMID: 8165623.
        View in: PubMed
      229. Mesters RM, Heeb MJ, Griffin J. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry. 1993 Nov 30; 32(47):12656-63. PMID: 8251484.
        View in: PubMed
      230. Gruber A, Pál A, Kiss RG, Sas G, Griffin J. Generation of activated protein C during thrombolysis. Lancet. 1993 Nov 20; 342(8882):1275-6. PMID: 7901587.
        View in: PubMed
      231. Griffin J, Evatt B, Wideman C, Fernández JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood. 1993 Oct 01; 82(7):1989-93. PMID: 8400251.
        View in: PubMed
      232. Tsay W, Greengard JS, Montgomery RR, McPherson RA, Fucci JC, Koerper MA, Coughlin J, Griffin J. Genetic mutations in ten unrelated American patients with symptomatic type 1 protein C deficiency. Blood Coagul Fibrinolysis. 1993 Oct; 4(5):791-6. PMID: 8292730.
        View in: PubMed
      233. Hanson SR, Griffin J, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest. 1993 Oct; 92(4):2003-12. PMID: 8408654; PMCID: PMC288368.
      234. Mesters RM, Heeb MJ, Griffin J. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Protein Sci. 1993 Sep; 2(9):1482-9. PMID: 8401232; PMCID: PMC2142455.
      235. Conard J, Bauer KA, Gruber A, Griffin J, Schwarz HP, Horellou MH, Samama MM, Rosenberg RD. Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency. Blood. 1993 Aug 15; 82(4):1159-64. PMID: 8353282.
        View in: PubMed
      236. Fernández JA, Heeb MJ, Griffin J. Identification of residues 413-433 of plasma protein S as essential for binding to C4b-binding protein. J Biol Chem. 1993 Aug 05; 268(22):16788-94. PMID: 7688369.
        View in: PubMed
      237. Phillips DJ, Greengard JS, Fernandez JA, Ribeiro M, Evatt BL, Griffin J, Hooper WC. Protein S, an antithrombotic factor, is synthesized and released by neural tumor cells. J Neurochem. 1993 Jul; 61(1):344-7. PMID: 8515282.
        View in: PubMed
      238. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin J. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993 Feb 05; 268(4):2872-7. PMID: 8428962.
        View in: PubMed
      239. Berrettini M, Schleef RR, Heeb MJ, Hopmeier P, Griffin J. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. J Biol Chem. 1992 Oct 05; 267(28):19833-9. PMID: 1400299.
        View in: PubMed
      240. Bakker HM, Tans G, Janssen-Claessen T, Thomassen MC, Hemker HC, Griffin J, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem. 1992 Aug 15; 208(1):171-8. PMID: 1387359.
        View in: PubMed
      241. Griffin J, Gruber A, Fernández JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood. 1992 Jun 15; 79(12):3203-11. PMID: 1534488.
        View in: PubMed
      242. Gruber A, Griffin J. Direct detection of activated protein C in blood from human subjects. Blood. 1992 May 01; 79(9):2340-8. PMID: 1571547.
        View in: PubMed
      243. Greengard JS, Griffin J. High molecular weight kininogen receptor. Methods Enzymol. 1992; 215:369-82. PMID: 1331710.
        View in: PubMed
      244. Mesters RM, Houghten RA, Griffin J. Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J Biol Chem. 1991 Dec 25; 266(36):24514-9. PMID: 1761551.
        View in: PubMed
      245. Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci U S A. 1991 Dec 15; 88(24):11241-5. PMID: 1722324; PMCID: PMC53110.
      246. Gruber A, Harker LA, Hanson SR, Kelly AB, Griffin J. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation. 1991 Dec; 84(6):2454-62. PMID: 1835678.
        View in: PubMed
      247. Heeb MJ, Gruber A, Griffin J. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. J Biol Chem. 1991 Sep 15; 266(26):17606-12. PMID: 1716632.
        View in: PubMed
      248. Vicente V, España F, Tabernero D, Estellés A, Aznar J, Hendl S, Griffin J. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. Blood. 1991 Jul 15; 78(2):416-22. PMID: 1648982.
        View in: PubMed
      249. Geiger M, Priglinger U, Griffin J, Binder BR. Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase. J Biol Chem. 1991 Jun 25; 266(18):11851-7. PMID: 1646816.
        View in: PubMed
      250. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin J. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991 Jun 15; 77(12):2641-8. PMID: 2043766.
        View in: PubMed
      251. España F, Gilabert J, Aznar J, Estellés A, Kobayashi T, Griffin J. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia. Am J Obstet Gynecol. 1991 May; 164(5 Pt 1):1310-6. PMID: 1852102.
        View in: PubMed
      252. España F, Gruber A, Heeb MJ, Hanson SR, Harker LA, Griffin J. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons. Blood. 1991 Apr 15; 77(8):1754-60. PMID: 1849759.
        View in: PubMed
      253. España F, Estelles A, Griffin J, Aznar J. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma. Thromb Haemost. 1991 Jan 23; 65(1):46-51. PMID: 1850876.
        View in: PubMed
      254. Kuhn LA, Griffin J, Fisher CL, Greengard JS, Bouma BN, España F, Tainer JA. Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor. Proc Natl Acad Sci U S A. 1990 Nov; 87(21):8506-10. PMID: 2172989; PMCID: PMC54985.
      255. Gruber A, Hanson SR, Kelly AB, Yan BS, Bang N, Griffin J, Harker LA. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation. 1990 Aug; 82(2):578-85. PMID: 2372904.
        View in: PubMed
      256. España F, Vicente V, Tabernero D, Scharrer I, Griffin J. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res. 1990 Aug 01; 59(3):593-608. PMID: 2173167.
        View in: PubMed
      257. Mack DP, Sluka JP, Shin JA, Griffin J, Simon MI, Dervan PB. Orientation of the putative recognition helix in the DNA-binding domain of Hin recombinase complexed with the hix site. Biochemistry. 1990 Jul 17; 29(28):6561-7. PMID: 2204416.
        View in: PubMed
      258. Heeb MJ, Bischoff R, Courtney M, Griffin J. Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358. J Biol Chem. 1990 Feb 05; 265(4):2365-9. PMID: 2298753.
        View in: PubMed
      259. España F, Estelles A, Griffin J, Aznar J, Gilabert J. Aprotinin (trasylol) is a competitive inhibitor of activated protein C. Thromb Res. 1989 Dec 15; 56(6):751-6. PMID: 2483763.
        View in: PubMed
      260. España F, Griffin J. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's. Thromb Res. 1989 Sep 15; 55(6):671-82. PMID: 2551066.
        View in: PubMed
      261. Geiger M, Huber K, Wojta J, Stingl L, Espana F, Griffin J, Binder BR. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo. Blood. 1989 Aug 01; 74(2):722-8. PMID: 2752144.
        View in: PubMed
      262. España F, Berrettini M, Griffin J. Purification and characterization of plasma protein C inhibitor. Thromb Res. 1989 Aug 01; 55(3):369-84. PMID: 2551064.
        View in: PubMed
      263. Berrettini M, Schleef RR, España F, Loskutoff DJ, Griffin J. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. J Biol Chem. 1989 Jul 15; 264(20):11738-43. PMID: 2787318.
        View in: PubMed
      264. Gladson CL, Schleef RR, Binder BR, Loskutoff DJ, Griffin J. A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitor. Blood. 1989 Jul; 74(1):173-81. PMID: 2787675.
        View in: PubMed
      265. Schwarz HP, Heeb MJ, Lottenberg R, Roberts H, Griffin J. Familial protein S deficiency with a variant protein S molecule in plasma and platelets. Blood. 1989 Jul; 74(1):213-21. PMID: 2526663.
        View in: PubMed
      266. Geiger M, White TM, Griffin J. Functional assays for protein C activity and protein C inhibitor activity in plasma. Thromb Haemost. 1989 Feb 28; 61(1):86-92. PMID: 2546280.
        View in: PubMed
      267. Gruber A, Griffin J, Harker LA, Hanson SR. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood. 1989 Feb 15; 73(3):639-42. PMID: 2917194.
        View in: PubMed
      268. Heeb MJ, Mosher D, Griffin J. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood. 1989 Feb; 73(2):455-61. PMID: 2521800.
        View in: PubMed
      269. Heeb MJ, España F, Griffin J. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood. 1989 Feb; 73(2):446-54. PMID: 2917184.
        View in: PubMed
      270. Heeb MJ, Schwarz HP, White T, Lämmle B, Berrettini M, Griffin J. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res. 1988 Oct 01; 52(1):33-43. PMID: 3201394.
        View in: PubMed
      271. Heeb MJ, Griffin J. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin. J Biol Chem. 1988 Aug 25; 263(24):11613-6. PMID: 3261294.
        View in: PubMed
      272. Lämmle B, Zuraw BL, Heeb MJ, Schwarz HP, Berrettini M, Curd JG, Griffin J. Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI. Thromb Haemost. 1988 Apr 08; 59(2):151-61. PMID: 3388291.
        View in: PubMed
      273. Geiger M, Heeb MJ, Binder BR, Griffin J. Competition of activated protein C and urokinase for a heparin-dependent inhibitor. FASEB J. 1988 Apr; 2(7):2263-7. PMID: 3350241.
        View in: PubMed
      274. Schwarz HP, Muntean W, Watzke H, Richter B, Griffin J. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood. 1988 Mar; 71(3):562-5. PMID: 2964259.
        View in: PubMed
      275. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin J. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988 Feb 25; 59(1):18-22. PMID: 2966450.
        View in: PubMed
      276. Tans G, Verkleij AJ, Yu J, Griffin J. Sulfatide bilayers as a surface for contact activation in human plasma. Biochem Biophys Res Commun. 1987 Dec 31; 149(3):1002-7. PMID: 3426605.
        View in: PubMed
      277. Gladson CL, Groncy P, Griffin J. Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency. Arch Dermatol. 1987 Dec; 123(12):1701a-1706a. PMID: 2961308.
        View in: PubMed
      278. Heeb MJ, España F, Geiger M, Collen D, Stump DC, Griffin J. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem. 1987 Nov 25; 262(33):15813-6. PMID: 2824468.
        View in: PubMed
      279. Tans G, Janssen-Claessen T, Rosing J, Griffin J. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa. Eur J Biochem. 1987 May 04; 164(3):637-42. PMID: 3552674.
        View in: PubMed
      280. Schwarz HP, Schernthaner G, Griffin J. Decreased plasma levels of protein S in well-controlled type I diabetes mellitus. Thromb Haemost. 1987 Apr 07; 57(2):240. PMID: 2955541.
        View in: PubMed
      281. Griffin J, Heeb MJ, Schwarz HP. Plasma protein S deficiency and thromboembolic disease. Prog Hematol. 1987; 15:39-49. PMID: 2971986.
        View in: PubMed
      282. Lämmle B, Berrettini M, Griffin J. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. Semin Thromb Hemost. 1987 Jan; 13(1):106-14. PMID: 3494310.
        View in: PubMed
      283. Schwarz HP, Heeb MJ, Lämmle B, Berrettini M, Griffin J. Quantitative immunoblotting of plasma and platelet protein S. Thromb Haemost. 1986 Dec 15; 56(3):382-6. PMID: 2436335.
        View in: PubMed
      284. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin J. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood. 1986 Dec; 68(6):1218-23. PMID: 3096399.
        View in: PubMed
      285. Cembrowski GS, Griffin J, Mosher DF. Diagnostic efficacy of six plasma proteins in evaluating consumptive coagulopathies. Use of receiver operating characteristic curves to compare antithrombin III, plasminogen, alpha 2-plasmin inhibitor, fibronectin, prothrombin, and protein C. Arch Intern Med. 1986 Oct; 146(10):1997-2002. PMID: 3767544.
        View in: PubMed
      286. Berrettini M, Lämmle B, White T, Heeb MJ, Schwarz HP, Zuraw B, Curd J, Griffin J. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood. 1986 Aug; 68(2):455-62. PMID: 3730610.
        View in: PubMed
      287. Lämmle B, Berrettini M, Griffin J. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma. Anal Biochem. 1986 Jul; 156(1):118-25. PMID: 3638135.
        View in: PubMed
      288. Bouma BN, Kerbiriou DM, Baker J, Griffin J. Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency. J Clin Invest. 1986 Jul; 78(1):170-6. PMID: 3487556; PMCID: PMC329546.
      289. Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin J. Binding of coagulation factor XI to washed human platelets. Biochemistry. 1986 Jul 01; 25(13):3884-90. PMID: 3017409.
        View in: PubMed
      290. Podack ER, Dahlbäck B, Griffin J. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. J Biol Chem. 1986 Jun 05; 261(16):7387-92. PMID: 3754869.
        View in: PubMed
      291. Bezeaud A, Drouet L, Leverger G, Griffin J, Guillin MC. Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors. J Pediatr. 1986 May; 108(5 Pt 1):698-701. PMID: 2939229.
        View in: PubMed
      292. Lämmle B, Berrettini M, Schwarz HP, Heeb MJ, Griffin J. Quantitative immunoblotting assay of blood coagulation factor XII. Thromb Res. 1986 Mar 15; 41(6):747-59. PMID: 3085274.
        View in: PubMed
      293. Schwarz HP, Heeb MJ, Wencel-Drake JD, Griffin J. Identification and quantitation of protein S in human platelets. Blood. 1985 Dec; 66(6):1452-5. PMID: 2933098.
        View in: PubMed
      294. Sas G, Blaskó G, Petrö I, Griffin J. A protein S deficient family with portal vein thrombosis. Thromb Haemost. 1985 Oct 30; 54(3):724. PMID: 2935967.
        View in: PubMed
      295. Bock PE, Shore JD, Tans G, Griffin J. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains. J Biol Chem. 1985 Oct 15; 260(23):12434-43. PMID: 3850090.
        View in: PubMed
      296. Cosio FG, Harker C, Batard MA, Brandt JT, Griffin J. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med. 1985 Aug; 106(2):218-22. PMID: 3160800.
        View in: PubMed
      297. Lämmle B, Griffin J. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Clin Haematol. 1985 Jun; 14(2):281-342. PMID: 2994929.
        View in: PubMed
      298. Sakata Y, Curriden S, Lawrence D, Griffin J, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci U S A. 1985 Feb; 82(4):1121-5. PMID: 3871946; PMCID: PMC397206.
      299. Greengard JS, Griffin J. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry. 1984 Dec 18; 23(26):6863-9. PMID: 6099145.
        View in: PubMed
      300. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin J. Plasma protein S deficiency in familial thrombotic disease. Blood. 1984 Dec; 64(6):1297-300. PMID: 6238642.
        View in: PubMed
      301. Gardiner JE, Griffin J. Studies on human protein C inhibitor in normal and Factor V/VIII deficient plasmas. Thromb Res. 1984 Nov 01; 36(3):197-203. PMID: 6549082.
        View in: PubMed
      302. Griffin J, Bezeaud A, Evatt B, Mosher D. Studies of protein C in thromboembolic disease. Ric Clin Lab. 1984 Jul-Sep; 14(3):469-73. PMID: 6395293.
        View in: PubMed
      303. Griffin J. Clinical studies of protein C. Semin Thromb Hemost. 1984 Apr; 10(2):162-6. PMID: 6377499.
        View in: PubMed
      304. Fulcher CA, Gardiner JE, Griffin J, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood. 1984 Feb; 63(2):486-9. PMID: 6419799.
        View in: PubMed
      305. Walsh PN, Tuszynski GP, Greengard JS, Griffin J. The possible role of platelets in bypassing the contact phase of blood coagulation. Haematologia (Budap). 1984; 17(2):169-78. PMID: 6534825.
        View in: PubMed
      306. Branson HE, Katz J, Marble R, Griffin J. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet. 1983 Nov 19; 2(8360):1165-8. PMID: 6139528.
        View in: PubMed
      307. Bouma BN, Vlooswijk RA, Griffin J. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen. Blood. 1983 Nov; 62(5):1123-31. PMID: 6626744.
        View in: PubMed
      308. van der Graaf F, Koedam JA, Griffin J, Bouma BN. Interaction of human plasma kallikrein and its light chain with C1 inhibitor. Biochemistry. 1983 Sep 27; 22(20):4860-6. PMID: 6556071.
        View in: PubMed
      309. van der Graaf F, Greengard JS, Bouma BN, Kerbiriou DM, Griffin J. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. J Biol Chem. 1983 Aug 25; 258(16):9669-75. PMID: 6604052.
        View in: PubMed
      310. Tans G, Rosing J, Griffin J. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor). J Biol Chem. 1983 Jul 10; 258(13):8215-22. PMID: 6553053.
        View in: PubMed
      311. Miles LA, Greengard JS, Griffin J. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen. Thromb Res. 1983 Feb 15; 29(4):407-17. PMID: 6344314.
        View in: PubMed
      312. Tans G, Griffin J. Initiation of contact activation by sulfatides. Adv Exp Med Biol. 1983; 156:63-72. PMID: 6602464.
        View in: PubMed
      313. Bouma BN, Vlooswijk RA, Griffin J. Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogen. Adv Exp Med Biol. 1983; 156:109-13. PMID: 6552836.
        View in: PubMed
      314. Gardiner JE, Griffin J. Human protein C and thromboembolic disease. Prog Hematol. 1983; 13:265-78. PMID: 6422505.
        View in: PubMed
      315. van der Graaf F, Tans G, Bouma BN, Griffin J. Isolation and functional properties of the heavy and light chains of human plasma kallikrein. J Biol Chem. 1982 Dec 10; 257(23):14300-5. PMID: 6815193.
        View in: PubMed
      316. Marlar RA, Kleiss AJ, Griffin J. An alternative extrinsic pathway of human blood coagulation. Blood. 1982 Dec; 60(6):1353-8. PMID: 7139124.
        View in: PubMed
      317. Griffin J, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood. 1982 Jul; 60(1):261-4. PMID: 6896290.
        View in: PubMed
      318. Miles LA, Plow EF, Donnelly KJ, Hougie C, Griffin J. A bleeding disorder due to deficiency of alpha 2-antiplasmin. Blood. 1982 Jun; 59(6):1246-51. PMID: 7082827.
        View in: PubMed
      319. Marlar RA, Kleiss AJ, Griffin J. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood. 1982 May; 59(5):1067-72. PMID: 6803853.
        View in: PubMed
      320. Tans G, Griffin J. Properties of sulfatides in factor-XII-dependent contact activation. Blood. 1982 Jan; 59(1):69-75. PMID: 6914902.
        View in: PubMed
      321. Cochrane CG, Griffin J. The biochemistry and pathophysiology of the contact system of plasma. Adv Immunol. 1982; 33:241-306. PMID: 6182767.
        View in: PubMed
      322. Griffin J, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981 Nov; 68(5):1370-3. PMID: 6895379; PMCID: PMC370934.
      323. Miles LA, Burnier JP, Verlander MS, Goodman M, Kleiss AJ, Griffin J. Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents. Blood. 1981 Jun; 57(6):1015-24. PMID: 6452920.
        View in: PubMed
      324. Marlar RA, Kleiss AJ, Griffin J. Human protein C: inactivation of factors V and VIII in plasma by the activated molecule. Ann N Y Acad Sci. 1981; 370:303-10. PMID: 6791548.
        View in: PubMed
      325. Marlar RA, Griffin J. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma. Ann N Y Acad Sci. 1981; 370:325-35. PMID: 6943963.
        View in: PubMed
      326. Walsh PN, Griffin J. Platelet-coagulant protein interactions in contact activation. Ann N Y Acad Sci. 1981; 370:241-52. PMID: 7023319.
        View in: PubMed
      327. Walsh PN, Griffin J. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood. 1981 Jan; 57(1):106-18. PMID: 7004531.
        View in: PubMed
      328. Marlar RA, Griffin J. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest. 1980 Nov; 66(5):1186-9. PMID: 6253526; PMCID: PMC371561.
      329. Bouma BN, Kerbiriou DM, Vlooswijk RA, Griffin J. Immunological studies of prekallikrein, kallikrein, and high-molecular-weight kininogen in normal and deficient plasmas and in normal plasma after cold-dependent activation. J Lab Clin Med. 1980 Oct; 96(4):693-709. PMID: 6903191.
        View in: PubMed
      330. Kerbiriou DM, Bouma BN, Griffin J. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. J Biol Chem. 1980 May 10; 255(9):3952-8. PMID: 6154706.
        View in: PubMed
      331. Bouma BN, Miles LA, Beretta G, Griffin J. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate. Biochemistry. 1980 Mar 18; 19(6):1151-60. PMID: 6768384.
        View in: PubMed
      332. Wiggins RC, Loskutoff DJ, Cochrane CG, Griffin J, Edgington TS. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest. 1980 Jan; 65(1):197-206. PMID: 6444222; PMCID: PMC371355.
      333. Seligsohn U, Osterud B, Brown SF, Griffin J, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest. 1979 Oct; 64(4):1056-65. PMID: 479368; PMCID: PMC372216.
      334. Cochrane CG, Griffin J. Molecular assembly in the contact phase of the Hageman factor system. Am J Med. 1979 Oct; 67(4):657-64. PMID: 386794.
        View in: PubMed
      335. Griffin J, Beretta G. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII). Adv Exp Med Biol. 1979; 120B:39-51. PMID: 517240.
        View in: PubMed
      336. Griffin J, Cochrane CG. Recent advances in the understanding of contact activation reactions. Semin Thromb Hemost. 1979; 5(4):254-73. PMID: 386517.
        View in: PubMed
      337. Wiggins RC, Cochrane CG, Griffin J. Rabbit blood coagulation factor XI. Purification and properties. Thromb Res. 1979; 15(3-4):475-86. PMID: 494156.
        View in: PubMed
      338. Wiggins RC, Cochrane CG, Griffin J. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII). Thromb Res. 1979; 15(3-4):487-95. PMID: 494157.
        View in: PubMed
      339. Seligsohn U, Osterud B, Griffin J, Rapaport SI. Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VII. Thromb Res. 1978 Dec; 13(6):1049-56. PMID: 749262.
        View in: PubMed
      340. Osterud B, Bouma BN, Griffin J. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem. 1978 Sep 10; 253(17):5946-51. PMID: 681330.
        View in: PubMed
      341. Griffin J. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci U S A. 1978 Apr; 75(4):1998-2002. PMID: 273926; PMCID: PMC392470.
      342. Revak SD, Cochrane CG, Bouma BN, Griffin J. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. J Exp Med. 1978 Mar 01; 147(3):719-29. PMID: 632748; PMCID: PMC2184209.
      343. Bouma BN, Griffin J. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma. J Lab Clin Med. 1978 Jan; 91(1):148-55. PMID: 73563.
        View in: PubMed
      344. Davis S, Furie BC, Griffin J, Furie B, Willey R. Circulating inhibitors of blood coagulation associated with procainamide-induced lupus erythematosus. Am J Hematol. 1978; 4(4):401-7. PMID: 717399.
        View in: PubMed
      345. Convert O, Griffin J, Di Bello C, Nicolas P, Cohen P. Selectively enriched 13C-labeled proline-7 and 13C-labeled leucine-8 ocytocins as probes for the analysis of peptide hormone interactions with bovine neurophysin I using 13C nuclear magnetic resonance spectroscopy. Biochemistry. 1977 Nov 15; 16(23):5061-5. PMID: 562184.
        View in: PubMed
      346. Wiggins RC, Bouma BN, Cochrane CG, Griffin J. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Proc Natl Acad Sci U S A. 1977 Oct; 74(10):4636-40. PMID: 270705; PMCID: PMC432002.
      347. Bouma BN, Griffin J. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977 Sep 25; 252(18):6432-7. PMID: 893417.
        View in: PubMed
      348. Griffin J, DiBello C, Alazard R, Nicolas P, Cohen P. Carbon-13 nuclear magnetic resonance studies of the binding of selectively 13C-enriched oxytocins to the neurophypophyseal protein, bovine neurophysin II. Biochemistry. 1977 Sep 20; 16(19):4194-8. PMID: 561612.
        View in: PubMed
      349. Revak SD, Cochrane CG, Griffin J. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. J Clin Invest. 1977 Jun; 59(6):1167-75. PMID: 864009; PMCID: PMC372330.
      350. Di Bello C, Griffin J. Circular dichroism and absorbance properties of nitrotyrosyl chromophores in staphylococcal nuclease and in a model diketopiperazine. J Biol Chem. 1975 Feb 25; 250(4):1445-50. PMID: 234457.
        View in: PubMed
      351. Cohen P, Camier M, Wolff J, Alazard R, Cohen JS, Griffin J. Studies of bovine neurophysin-neurohypophyseal hormone interactions. Ann N Y Acad Sci. 1975 Feb 21; 248:463-79. PMID: 235235.
        View in: PubMed
      352. Griffin J, Furie B, Schechter AN. Application of nuclear magnetic resonance spectroscopy to proteins. Biochimie. 1975; 57(4):453-60. PMID: 1148335.
        View in: PubMed
      353. Alazard R, Cohen P, Cohen JS, Griffin J. Interactions of bovine neurophysin II with oxytocin and (8-lysine) vasopressin. High resolution proton nuclear magnetic resonance spectroscopy studies. J Biol Chem. 1974 Nov 10; 249(21):6895-900. PMID: 4423570.
        View in: PubMed
      354. Griffin J, Schechter AN, Cohen JS. Nuclear magnetic resonance studies of a ribonuclease-dinucleoside phosphonate complex and their implications for the mechanism of the enzyme. Ann N Y Acad Sci. 1973 Dec 31; 222:693-708. PMID: 4522440.
        View in: PubMed
      355. Griffin J, Alazard R, Cohen P. Complex formation between bovine neurophysin-I and oxytocin, vasopressin, and tripeptide analogs of their NH2-terminal region. Absorbance and circular dichroism difference spectroscopic studies. J Biol Chem. 1973 Dec 10; 248(23):7975-8. PMID: 4796247.
        View in: PubMed
      356. Griffin J, Cohen JS, Schechter AN. The assignment of an exchangeable low-field NH proton resonance of ribonuclease A to the active-site histidine-119. Biochemistry. 1973 May 22; 12(11):2096-9. PMID: 4735881.
        View in: PubMed
      357. Griffin J, Criddle RS. Substrate-inhibited lactate dehydrogenase. Reaction mechanism and essential role of dissociated subunits. Biochemistry. 1970 Mar 03; 9(5):1195-205. PMID: 4313938.
        View in: PubMed
      John's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _